Refine
Document Type
- Article (27)
Has Fulltext
- yes (27)
Is part of the Bibliography
- no (27)
Keywords
- prostate cancer (5)
- Prostate cancer (4)
- Machine learning (3)
- Penile carcinomas (3)
- radical prostatectomy (3)
- Tumor microenvironment (2)
- immunohistochemistry (2)
- ALK gene (1)
- ASAP (1)
- Alcohol consumption (1)
- Antibodies (1)
- Artificial intelligence (1)
- Awareness campaign (1)
- BCOR (1)
- Blood pressure (1)
- Caco-2 cells (1)
- Cancer check up (1)
- Cell motility (1)
- Colorectal cancer (1)
- Cytoskeletal proteins (1)
- Diagnostic markers (1)
- D’Amico classification (1)
- ERK inhibitor (1)
- Ewing-like (1)
- Eyes (1)
- FFPE (1)
- Gene fusion (1)
- Glaucoma (1)
- Gleason Score (1)
- Gleason score (1)
- HPV infection (1)
- HoLEP (1)
- Holmium laser enucleation (1)
- IHC (1)
- Immunohistochemistry techniques (1)
- Incidental prostate cancer (1)
- Interleukin-17A (1)
- LCD-Array (1)
- Lung adenocarcinoma (1)
- MEK inhibitor (1)
- Medical imaging (1)
- Metastasis (1)
- Metastatic tumors (1)
- Morphometry (1)
- Multiparametric MRI (1)
- Nerve fibers (1)
- Next generation sequencing (1)
- Next-generation sequencing (1)
- PD-L1 (1)
- PSA (1)
- PSA screening (1)
- PSA-Screening (1)
- Pathology (1)
- Preclinical research (1)
- Prediction (1)
- Predictive markers (1)
- Preventive medicine (1)
- Prognostic markers (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Prävention (1)
- Quantitative features (1)
- RGAG1 (1)
- Radiomics (1)
- SW480 cells (1)
- SWATH (1)
- Sanger Sequencing (1)
- Sarcoma (1)
- Screening (1)
- Statistical analysis (1)
- Survival (1)
- TUR-P (1)
- Tinnitus (1)
- Tissue microarray (1)
- Tomography (1)
- Translational research (1)
- Transurethral resection of the prostate (1)
- Urological oncology (1)
- Viral infection (1)
- Viral oncology (1)
- Vorsorgeuntersuchung (1)
- adjuvant chemotherapy (1)
- biomarker (1)
- bladder cancer (1)
- cellular heterogeneity (1)
- chemotherapy (1)
- computational pathology (1)
- concordance (1)
- consensus classification (1)
- correlation (1)
- deep learning (1)
- deferred treatment (1)
- delayed treatment (1)
- diffusion-weighted magnetic resonance imaging (1)
- double negative (1)
- downgrading (1)
- drug resistance (1)
- ensemble cNN (1)
- fusion biopsy (1)
- histological outcomes (1)
- histology (1)
- hypertension and anti-hypertensive treatment (1)
- intrahepatic cholangiocarcinoma (1)
- inverse stage migration (1)
- liver fibrosis (1)
- metastasis (1)
- molecular diagnostic techniques (1)
- molecular subtyping (1)
- molecular typing (1)
- mouse tumor model (1)
- multiplexed immunofluorescence (1)
- neoadjuvant chemoradiotherapy (1)
- oncogenic RAS (1)
- oral cavity cancer (1)
- overall survival (1)
- p16 (1)
- pancreatic ductal adenocarcinoma (1)
- predictive biomarker (1)
- pressure cycling technology (1)
- prognosis (1)
- prostate neoplasm (1)
- prostate-specific antigen (1)
- proteome (1)
- psoriasis (1)
- radical prostatecomy (1)
- single-cell proteomics (1)
- stomach neoplasms (1)
- systematic biopsy (1)
- telmisartan (1)
- tumor (1)
- tumor weight (1)
- undifferentiated pleomorphic sarcoma (1)
- upgrading (1)
- vascular dysfunction and inflammation (1)
- waiting time (1)
- Öffentlichkeit (1)
Institute
Intrahepatic cholangiocarcinoma (iCCA) is the most frequent subtype of cholangiocarcinoma (CCA), and the incidence has globally increased in recent years. In contrast to surgically treated iCCA, data on the impact of fibrosis on survival in patients undergoing palliative chemotherapy are missing. We retrospectively analyzed the cases of 70 patients diagnosed with iCCA between 2007 and 2020 in our tertiary hospital. Histopathological assessment of fibrosis was performed by an expert hepatobiliary pathologist. Additionally, the fibrosis-4 score (FIB-4) was calculated as a non-invasive surrogate marker for liver fibrosis. For overall survival (OS) and progression-free survival (PFS), Kaplan–Meier curves and Cox-regression analyses were performed. Subgroup analyses revealed a median OS of 21 months (95% CI = 16.7–25.2 months) and 16 months (95% CI = 7.6–24.4 months) for low and high fibrosis, respectively (p = 0.152). In non-cirrhotic patients, the median OS was 21.8 months (95% CI = 17.1–26.4 months), compared with 9.5 months (95% CI = 4.6–14.3 months) in cirrhotic patients (p = 0.007). In conclusion, patients with iCCA and cirrhosis receiving palliative chemotherapy have decreased OS rates, while fibrosis has no significant impact on OS or PFS. These patients should not be prevented from state-of-the-art first-line chemotherapy.
Localized prostate cancer exhibits multiple genomic alterations and heterogeneity at the proteomic level. Single-cell technologies capture important cell-to-cell variability responsible for heterogeneity in biomarker expression that may be overlooked when molecular alterations are based on bulk tissue samples. This study aims to identify prognostic biomarkers and describe the heterogeneity of prostate cancer and the associated microenvironment by simultaneously quantifying 36 proteins using single-cell mass cytometry analysis of over 1.6 million cells from 58 men with localized prostate cancer. We perform this task, using a high-dimensional clustering pipeline named Franken to describe subpopulations of immune, stromal, and prostate cells, including changes occurring in tumor tissues and high-grade disease that provide insights into the coordinated progression of prostate cancer. Our results further indicate that men with localized disease already harbor rare subpopulations that typically occur in castration-resistant and metastatic disease.
Our purpose was to analyze the robustness and reproducibility of magnetic resonance imaging (MRI) radiomic features. We constructed a multi-object fruit phantom to perform MRI acquisition as scan-rescan using a 3 Tesla MRI scanner. We applied T2-weighted (T2w) half-Fourier acquisition single-shot turbo spin-echo (HASTE), T2w turbo spin-echo (TSE), T2w fluid-attenuated inversion recovery (FLAIR), T2 map and T1-weighted (T1w) TSE. Images were resampled to isotropic voxels. Fruits were segmented. The workflow was repeated by a second reader and the first reader after a pause of one month. We applied PyRadiomics to extract 107 radiomic features per fruit and sequence from seven feature classes. We calculated concordance correlation coefficients (CCC) and dynamic range (DR) to obtain measurements of feature robustness. Intraclass correlation coefficient (ICC) was calculated to assess intra- and inter-observer reproducibility. We calculated Gini scores to test the pairwise discriminative power specific for the features and MRI sequences. We depict Bland Altmann plots of features with top discriminative power (Mann–Whitney U test). Shape features were the most robust feature class. T2 map was the most robust imaging technique (robust features (rf), n = 84). HASTE sequence led to the least amount of rf (n = 20). Intra-observer ICC was excellent (≥ 0.75) for nearly all features (max–min; 99.1–97.2%). Deterioration of ICC values was seen in the inter-observer analyses (max–min; 88.7–81.1%). Complete robustness across all sequences was found for 8 features. Shape features and T2 map yielded the highest pairwise discriminative performance. Radiomics validity depends on the MRI sequence and feature class. T2 map seems to be the most promising imaging technique with the highest feature robustness, high intra-/inter-observer reproducibility and most promising discriminative power.
Introduction and Objective: Identifying patients that benefit from cisplatin-based adjuvant chemotherapy is a major issue in the management of muscle-invasive bladder cancer (MIBC). The purpose of this study is to correlate “luminal” and “basal” type protein expression with histological subtypes, to investigate the prognostic impact on survival after adjuvant chemotherapy and to define molecular consensus subtypes of “double negative” patients (i.e., without expression of CK5/6 or GATA3).
Materials and Methods: We performed immunohistochemical (IHC) analysis of CK5/6 and GATA3 for surrogate molecular subtyping in 181 MIBC samples. The mRNA expression profiles for molecular consensus classification were determined in CK5/6 and GATA3 (double) negative cases using a transcriptome panel with 19.398 mRNA targets (HTG Molecular Diagnostics). Data of 110 patients undergoing radical cystectomy were available for survival analysis.
Results: The expression of CK5/6 correlated with squamous histological subtype (96%) and expression of GATA3 was associated with micropapillary histology (100%). In the multivariate Cox-regression model, patients receiving adjuvant chemotherapy had a significant survival benefit (hazard ratio [HR]: 0.19 95% confidence interval [CI]: 0.1–0.4, p < 0.001) and double-negative cases had decreased OS (HR: 4.07; 95% CI: 1.5–10.9, p = 0.005). Double negative cases were classified as NE-like (30%), stroma-rich (30%), and Ba/Sq (40%) consensus molecular subtypes and displaying different histological subtypes.
Background: To study neoadjuvant chemoradiotherapy (nCRT) and potential predictive factors for response in locally advanced oral cavity cancer (LA-OCC).
Methods: The INVERT trial is an ongoing single-center, prospective phase 2, proof-of-principle trial. Operable patients with stage III-IVA squamous cell carcinomas of the oral cavity were eligible and received nCRT consisting of 60 Gy with concomitant cisplatin and 5-fluorouracil. Surgery was scheduled 6-8 weeks after completion of nCRT. Explorative, multiplex immunohistochemistry (IHC) was performed on pretreatment tumor specimen, and diffusion-weighted magnetic resonance imaging (DW-MRI) was conducted prior to, during nCRT (day 15), and before surgery to identify potential predictive biomarkers and imaging features. Primary endpoint was the pathological complete response (pCR) rate.
Results: Seventeen patients with stage IVA OCC were included in this interim analysis. All patients completed nCRT. One patient died from pneumonia 10 weeks after nCRT before surgery. Complete tumor resection (R0) was achieved in 16/17 patients, of whom 7 (41%, 95% CI: 18-67%) showed pCR. According to the Clavien-Dindo classification, grade 3a and 3b complications were found in 4 (25%) and 5 (31%) patients, respectively; grade 4-5 complications did not occur. Increased changes in the apparent diffusion coefficient signal intensities between MRI at day 15 of nCRT and before surgery were associated with better response (p=0.022). Higher abundances of programmed cell death protein 1 (PD1) positive cytotoxic T-cells (p=0.012), PD1+ macrophages (p=0.046), and cancer-associated fibroblasts (CAFs, p=0.036) were associated with incomplete response to nCRT.
Conclusion: nCRT for LA-OCC followed by radical surgery is feasible and shows high response rates. Larger patient cohorts from randomized trials are needed to further investigate nCRT and predictive biomarkers such as changes in DW-MRI signal intensities, tumor infiltrating immune cells, and CAFs.
Background: Prostate cancer is a major health concern in aging men. Paralleling an aging society, prostate cancer prevalence increases emphasizing the need for efcient diagnostic algorithms.
Methods: Retrospectively, 106 prostate tissue samples from 48 patients (mean age,
66 ± 6.6 years) were included in the study. Patients sufered from prostate cancer (n = 38) or benign prostatic hyperplasia (n = 10) and were treated with radical prostatectomy or Holmium laser enucleation of the prostate, respectively. We constructed tissue microarrays (TMAs) comprising representative malignant (n = 38) and benign (n = 68) tissue cores. TMAs were processed to histological slides, stained, digitized and assessed for the applicability of machine learning strategies and open–source tools in diagnosis of prostate cancer. We applied the software QuPath to extract features for shape, stain intensity, and texture of TMA cores for three stainings, H&E, ERG, and PIN-4. Three machine learning algorithms, neural network (NN), support vector machines (SVM), and random forest (RF), were trained and cross-validated with 100 Monte Carlo random splits into 70% training set and 30% test set. We determined AUC values for single color channels, with and without optimization of hyperparameters by exhaustive grid search. We applied recursive feature elimination to feature sets of multiple color transforms.
Results: Mean AUC was above 0.80. PIN-4 stainings yielded higher AUC than H&E and
ERG. For PIN-4 with the color transform saturation, NN, RF, and SVM revealed AUC of 0.93 ± 0.04, 0.91 ± 0.06, and 0.92 ± 0.05, respectively. Optimization of hyperparameters improved the AUC only slightly by 0.01. For H&E, feature selection resulted in no increase of AUC but to an increase of 0.02–0.06 for ERG and PIN-4.
Conclusions: Automated pipelines may be able to discriminate with high accuracy between malignant and benign tissue. We found PIN-4 staining best suited for classifcation. Further bioinformatic analysis of larger data sets would be crucial to evaluate the reliability of automated classifcation methods for clinical practice and to evaluate potential discrimination of aggressiveness of cancer to pave the way to automatic precision medicine.